Why Controlled Drug Prescriptions Still Require Hardcopy Signed in Indelible Ink in a Digital World

The short answer is section 15 of the Misuse of Drugs Regulations 2001.

However, this should not be the case. Technology has advanced to the point that makes this law obsolete. We are now using digital prescriptions for all medicines but controlled drug. It solved many problems and make healthcare more accessible.

Errors due to illegible prescriptions have mostly disappeared. In primary care, NHS BSA developed the eFP10 system which enables fully digital prescriptions even for controlled drugs. This is the only known exception to the indelible ink requirement as we all know.

But why do the private and hospital sectors still have this requirement? I think it's because most, if not all, pharmacists remain cautious. They can exercise their discretion to refuse to dispense prescriptions if they are legally invalid. Missing the indelible ink requirement would count as legally invalid and thus, to avoid operational chaos, private and hospital providers choose to keep this requirement.

But first, let's step back. What does the law say? The law is actually made by secondary legislation. Section 15 of the Misuse of Drugs Regulations 2001 is the basis for this indelible ink requirement. Until this is repealed, it remains the law. It was not made by Parliament, but rather by civil servants on behalf of the ministers exercising their power to legislate. Brushing constitutional arguments aside, law-making in this way is much easier to reform as it does not need the usual parliamentary legislative process but rather the secondary legislation process, though that is resource intensive. Nevertheless, no reform has been done in this area.

The main point here is that there was no reform because there was no policy drive to change it and no business case for doing so.

If we trace back the law, we will see that it originates from the Misuse of Drugs (Safe Custody) Regulations 1973, which is a statutory instrument — also a secondary legislation. It doesn't make it any less of a law but in theory, it is easier to reform than primary legislation. The Shipman case reinforced the case for the law requiring indelible ink and thus, the law remains as it is.

But we are not in 1973 let alone 2000. Technology has evolved such that digital systems can and have solved the forgery problems that indelible ink was meant to prevent.

The paper-based requirement can create administrative friction even where the clinical decision itself is straightforward. But intuition is not a case for change. Reform needs a business case, and a business case needs data. So we need a measurement system that can quantify avoidable delay, duplication and handling without adding more work. I think AI could help with that.

The NHS is investing in AI across many domains including operational efficiency. One possible workstream is a tool that identifies waste in existing processes and makes it easier to build a case for changing them. The aim would be to make invisible waste measurable. Existing digital systems do not necessarily provide that view: local workarounds can solve immediate problems while leaving duplication, delay or unnecessary handling elsewhere in the process. So the first step is to measure that waste well enough to support a case for improvement.

I don't yet know the shape of this tool. But measurement is where it starts. This is what I'm planning to build next. If you have any ideas, do let me know. I would love to work with you.